Tyler D. Seckar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tyler D. Seckar has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Erle S. Robertson
The Tumor Virology Program, Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine at the University of Pennsylvania
2 shared publications Gregory S. Weinstein
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, United States
2 shared publications- Karthik Rajasekaran
Department of Otolaryngology—Head and Neck Surgery University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications Michael D. Feldman
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States
2 shared publicationsXiang Lin
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, United States; Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, United States
2 shared publications- Zhi Wei
New Jersey Institute of Technology
2 shared publications
Latest Publications
- 27 February 2026
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (7) , 1487-1513
Spatial Transcriptomics Profiling of Small Intestine Adenocarcinoma and Adenoma in Humans and a Murine Model with KRASG12D and Loss of CDKN2a-p16
- 27 February 2026
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (7) , 1487-1513
Spatial Transcriptomics Profiling of Small Intestine Adenocarcinoma and Adenoma in Humans and a Murine Model with KRASG12D and Loss of CDKN2a-p16
- 1 June 2021
- Published by Elsevier in Oral Oncology
- Vol. 117, 105305
The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
- 1 June 2021
- Published by Elsevier in Oral Oncology
- Vol. 117, 105305
The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
- Open Access
- 9 March 2021
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12, 637202
Detection of Microbial Agents in Oropharyngeal and Nasopharyngeal Samples of SARS-CoV-2 Patients
The novel coronavirus outbreak started in December 2019 and rapidly spread around the globe, leading to a global pandemic. Here we reported the association of microbial agents identified in oropharyngeal and nasopharyngeal samples from patients with SARS-CoV-2 infection, using a Pan-microarray based technology referred to as PathoChIP. To validate the efficiency of PathoChIP, reference viral genomes obtained from BEI resource and 25 SARS-CoV-2 positive clinical samples were tested. This technology successfully detected femtogram levels of SARS-CoV-2 viral RNA, which demonstrated greater sensitivity and specificity than conventional diagnostic techniques. Simultaneously, a broad range of other microorganisms, including other viruses, bacteria, fungi and parasites can be detected in those samples. We identified 7 viral, 12 bacterial and 6 fungal agents common across all clinical samples suggesting an associated microbial signature in individuals who are infected with SARS-CoV-2. This technology is robust and has a flexible detection methodology that can be employed to detect the presence of all human respiratory pathogens in different sample preparations with precision. It will be important for differentiating the causative agents of respiratory illnesses, including SARS-CoV-2.
- 9 March 2021
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12, 637202
Open AccessDetection of Microbial Agents in Oropharyngeal and Nasopharyngeal Samples of SARS-CoV-2 Patients
The novel coronavirus outbreak started in December 2019 and rapidly spread around the globe, leading to a global pandemic. Here we reported the association of microbial agents identified in oropharyngeal and nasopharyngeal samples from patients with SARS-CoV-2 infection, using a Pan-microarray based technology referred to as PathoChIP. To validate the efficiency of PathoChIP, reference viral genomes obtained from BEI resource and 25 SARS-CoV-2 positive clinical samples were tested. This technology successfully detected femtogram levels of SARS-CoV-2 viral RNA, which demonstrated greater sensitivity and specificity than conventional diagnostic techniques. Simultaneously, a broad range of other microorganisms, including other viruses, bacteria, fungi and parasites can be detected in those samples. We identified 7 viral, 12 bacterial and 6 fungal agents common across all clinical samples suggesting an associated microbial signature in individuals who are infected with SARS-CoV-2. This technology is robust and has a flexible detection methodology that can be employed to detect the presence of all human respiratory pathogens in different sample preparations with precision. It will be important for differentiating the causative agents of respiratory illnesses, including SARS-CoV-2.
- Open Access
- 21 January 2020
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (3) , 282-293
The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
Oncotarget | https://doi.org/10.18632/oncotarget.27436 Ryan M. Carey, Karthik Rajasekaran, Tyler Seckar, Xiang Lin, Zhi Wei, Charles C. L. Tong, Viran J. Ranasinghe, Jason G. Newman, Bert W. O'Malley Jr.,...
- 21 January 2020
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (3) , 282-293
Open AccessThe virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
Oncotarget | https://doi.org/10.18632/oncotarget.27436 Ryan M. Carey, Karthik Rajasekaran, Tyler Seckar, Xiang Lin, Zhi Wei, Charles C. L. Tong, Viran J. Ranasinghe, Jason G. Newman, Bert W. O'Malley Jr.,...